A carregar...

Mesothelin, a novel immunotherapy target for triple negative breast cancer

Mesothelin is a cell-surface glycoprotein present on mesothelial cells and elicits T-cell responses in a variety of cancers including pancreatic and ovarian cancer. Breast cancer is not known to express mesothelin. We postulated that mesothelin may be a unique tumor associated antigen in triple nega...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Tchou, Julia, Wang, Liang-Chuan, Selven, Ben, Zhang, Hongtao, Conejo-Garcia, Jose, Borghaei, Hossein, Vondeheide, Robert H, Albelda, Steven M., June, Carl H, Zhang, Paul J
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964602/
https://ncbi.nlm.nih.gov/pubmed/22418702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2018-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!